DOUGLAS RICHARD - 10 Jun 2025 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Director
Signature
/s/ Richard Douglas
Issuer symbol
ALDX
Transactions as of
10 Jun 2025
Net transactions value
$0
Form type
4
Filing time
12 Jun 2025, 16:27:13 UTC
Previous filing
14 Jun 2024
Next filing
13 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DOUGLAS RICHARD Director C/O ALDEYRA THERAPEUTICS, INC., 131 HARTWELL AVENUE, LEXINGTON /s/ Richard Douglas 12 Jun 2025 0001021015

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (Right to Buy) Award $0 +62,728 $0.000000 62,728 10 Jun 2025 Common Stock 62,728 $2.68 Direct F1
transaction ALDX Stock Option (Right to Buy) Award $0 +14,476 $0.000000 14,476 10 Jun 2025 Common Stock 14,476 $2.68 Direct F2
transaction ALDX Stock Option (Right to Buy) Award $0 +1,689 $0.000000 1,689 10 Jun 2025 Common Stock 1,689 $2.68 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
F2 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date.
F3 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.